Rodney Falk is the Founder and Emeritus Director of the Brigham and Women’s Hospital Amyloidosis Program, and Associate Professor of Medicine at Harvard Medical School. Boston MA USA. He has been involved with treating patients with amyloidosis for over 40 years and was previously at Boston University where he was a Professor of Medicine and Associate Director of The Boston University Amyloidosis Program. Dr Falk is a senior author or co-author on over 250 peer publications and has lectured nationally and internationally on cardiac topics in general and amyloid heart disease in particular.

• Chief, Department of Cardiology, Hôpital Bichat, Paris, France.
• Vice President (Research) of the board of the Assistance Publique-Hôpitaux de Paris network (38 hospitals).
• Professor of Cardiology at Université Paris-Cité, Paris, France
• Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research network.
• Chair of the French National University Council for Cardiology (Conseil National des Universités)
• Senior Professor (innovation chair) at Institut Universitaire de France, since 2022

Dr Steg has extensive experience as a clinical trialist in coronary artery disease and has authored more than 1 700 peer-reviewed articles. His H-Index is 149 and he has > 130 000 citations. He has been ”highly cited researcher” every year since 2014. He is Senior Associate Editor for Circulation.